Asensus Surgical, Inc. (ASXC)
NYSEAMERICAN: ASXC · IEX Real-Time Price · USD
0.245
+0.006 (2.64%)
May 2, 2024, 4:00 PM EDT - Market closed

Asensus Surgical Revenue

In the year 2023, Asensus Surgical had annual revenue of $8.58M with 21.02% growth. Revenue in the quarter ending December 31, 2023 was $5.43M with 120.41% year-over-year growth.

Revenue (ttm)
$8.58M
Revenue Growth
+21.02%
P/S Ratio
7.61
Revenue / Employee
$41,435
Employees
207
Market Cap
66.64M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.58M1.49M21.02%
Dec 31, 20227.09M-1.15M-13.91%
Dec 31, 20218.23M5.06M159.28%
Dec 31, 20203.18M-5.36M-62.78%
Dec 31, 20198.53M-15.57M-64.60%
Dec 31, 201824.10M16.99M238.94%
Dec 31, 20177.11M5.59M368.14%
Dec 31, 20161.52M--
Dec 31, 20150--
Dec 31, 2014401.00K-1.03M-71.98%
Dec 31, 20131.43M-684.00K-32.34%
Dec 31, 20122.12M--
Dec 31, 20110--
Dec 31, 20100--
Dec 31, 20090--
Dec 31, 20080--
Dec 31, 20070--
Dec 31, 20060--
Dec 31, 20050--
Dec 31, 20040--
Dec 31, 20030--
Dec 31, 200211.77M-8.65M-42.34%
Dec 31, 200120.42M-5.56M-21.40%
Dec 31, 200025.97M15.73M153.62%
Dec 31, 199910.24M-1.71M-14.34%
Dec 31, 199811.96M-18.30M-60.49%
Dec 31, 199730.26M9.35M44.75%
Dec 31, 199620.90M8.79M72.62%
Dec 31, 199512.11M2.38M24.42%
Dec 31, 19949.73M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Journey Medical 79.18M
MDxHealth 70.19M
Champions Oncology 49.22M
Precision BioSciences 48.73M
Pro-Dex 48.24M
Cryo-Cell International 31.37M
Celularity 14.79M
Revenue Rankings